HCW Biologics Inc. (HCWB)
NASDAQ: HCWB · Real-Time Price · USD
0.430
0.00 (0.00%)
Nov 4, 2024, 4:00 PM EST - Market closed
HCW Biologics Employees
HCW Biologics had 45 employees as of December 31, 2023. The number of employees increased by 1 or 2.27% compared to the previous year.
Employees
45
Change (1Y)
1
Growth (1Y)
2.27%
Revenue / Employee
$87,170
Profits / Employee
-$852,609
Market Cap
16.26M
Employees Chart
Employees History
Date | Employees | Change | Growth |
---|---|---|---|
Dec 31, 2023 | 45 | 1 | 2.27% |
Dec 31, 2022 | 44 | 0 | - |
Dec 31, 2021 | 44 | 4 | 10.00% |
Dec 31, 2020 | 40 | - | - |
Related Stocks
Company Name | Employees |
---|---|
China Jo-Jo Drugstores | 1,003 |
Trinity Biotech | 380 |
Cumberland Pharmaceuticals | 91 |
Cara Therapeutics | 55 |
AIM ImmunoTech | 28 |
Microbot Medical | 22 |
GeoVax Labs | 17 |
Talphera | 15 |
HCWB News
- 2 months ago - HCW Biologics Reports Second Quarter 2024 Financial Results and Business Highlights - Correction - GlobeNewsWire
- 2 months ago - HCW Biologics Reports Second Quarter 2024 Financial Results and Business Highlights - GlobeNewsWire
- 6 months ago - HCW Biologics Reports First Quarter 2024 Financial Results and Business Highlights - GlobeNewsWire
- 7 months ago - HCW Biologics Reports Fourth Quarter 2023 and Fiscal Year End Financial Results And Business Highlights - GlobeNewsWire
- 1 year ago - HCW Biologics Reports Third Quarter 2023 Financial Results And Recent Business Highlights - GlobeNewsWire
- 1 year ago - Investigator Sponsor of HCW Biologics' Phase 1 Clinical Trial Presented Human Data Readout and Anti-Cancer Mechanism of Action of HCW9218 at 38th SITC Annual Meeting - GlobeNewsWire
- 1 year ago - Masonic Cancer Center, University of Minnesota to Present Data in Poster Presentation Human Data Readout for Phase 1 Study to Evaluate HCW9218 in Solid Tumors at SITC 38th Annual Meeting - GlobeNewsWire
- 1 year ago - HCW Biologics Participating at H.C. Wainwright 25th Annual Global Investment Conference in New York on September 11 – 13, 2023 - GlobeNewsWire